Understanding Osteoporosis: Next Steps After Diagnosis

Discovering that you are at risk for osteoporosis can be concerning. It is crucial to take proactive measures by exploring lifestyle changes and available medications. Collaborate with your healthcare provider to determine the most suitable osteoporosis treatment for your needs.

Who is at Risk of Osteoporosis?

Osteoporosis affects over 200 million individuals globally, impacting both men and women. However, women who have undergone menopause are at the highest risk. Additional risk factors include family history and lifestyle choices such as alcohol consumption, smoking, and insufficient physical activity.

Osteoporosis does not present early symptoms, but once developed, individuals may face back pain, a decrease in height, a stooped posture, and bones that fracture easily.

Types of Fractures Associated with Osteoporosis

Vertebral fractures are among the most prevalent types of fractures associated with osteoporosis. These fractures can lead to deformities that vary in severity and may often be overlooked by medical professionals. Severe vertebral fractures can significantly increase the risk of subsequent fractures.

Other common fractures, such as hip fractures, often necessitate hospitalization, with statistics indicating that 20% of these cases can be fatal, and 50% may result in severe disability. The financial burden of treating osteoporotic fractures can lead to substantial medical expenses and impact overall quality of life, as osteoporosis is painful and can hinder daily activities.

Effective Treatments for Osteoporosis

Despite growing awareness, osteoporosis remains underdiagnosed and undertreated. Effective treatments encompass both preventive measures and pharmacological therapies. Typically, osteoporosis affects women over the age of fifty, who experience a gradual loss of bone mass. Premenopausal women lose approximately 0.3% of their bone density annually, while postmenopausal women may lose over 2%.

Estrogen Therapy

Estrogen is a key hormone in maintaining bone mass and has been extensively studied for osteoporosis treatment. It can reduce the incidence of fractures by nearly 50%; however, it is important to note that estrogen therapy may increase the risk of breast cancer by 2.5%.

Raloxifene (Evista)

Raloxifene is another medication prescribed for postmenopausal women, particularly those at high risk for breast cancer, as it can simultaneously lower the likelihood of developing breast cancer.

Calcium and Vitamin D

Calcium and vitamin D are essential for optimal bone health. These nutrients work synergistically, with vitamin D enhancing calcium absorption to strengthen bones. Additionally, they can improve muscle function, aiding balance and reducing fall risk, which is crucial for fracture prevention. Dosages may vary based on age.

Parathyroid Hormone (PTH)

Parathyroid hormone, secreted by the parathyroid gland, plays a pivotal role in regulating calcium levels in the body. Teriparatide, a new PTH drug, promotes the creation of new bone faster than it breaks down, effectively increasing bone density and lowering fracture risk in the hip, spine, and other areas.

Bisphosphonates

Bisphosphonates are designed to prevent bone density loss by inhibiting bone-resorbing cells. Research indicates that these medications can boost bone mass in the spine and hips, reducing fracture risk by approximately 50%. This is vital since bone strength correlates directly with bone mass.

Denosumab

Denosumab is a human monoclonal antibody used to combat bone loss and treat giant bone tumors. It functions by preventing bone-resorbing cells from operating, thereby decreasing the risk of fractures in both men and postmenopausal women. Administered as an injection, common side effects include muscle and joint pain, skin issues, and in rare cases, osteonecrosis of the jaw, characterized by jaw bone exposure and diminished blood circulation.

Conclusion

Osteoporosis can be effectively managed or prevented through lifestyle modifications and appropriate treatments. It is essential to consult your healthcare provider before making any changes to your lifestyle or starting new medications. Your doctor can guide you in finding the best osteoporosis treatment tailored to your needs.

References

  • Denosumab: Osteoporosis Canada. (2019, August 06). Retrieved January 10, 2021, from https://osteoporosis.ca/about-the-disease/treatment/denosumab/
  • Hu, X., Ma, S., Yang, C., Wang, W., & Chen, L. (2019). Relationship between senile osteoporosis and cardiovascular and cerebrovascular diseases. Experimental and Therapeutic Medicine. doi:10.3892/etm.2019.7518
  • Musculoskeletal conditions affect millions. (n.d.). Retrieved January 10, 2021, from https://www.who.int/news/item/27-10-2003-musculoskeletal-conditions-affect-millions
  • Miller, P. D. (2015). Management of severe osteoporosis. Expert Opinion on Pharmacotherapy, 17(4), 473-488. doi:10.1517/14656566.2016.1124856
  • Osteonecrosis of the Jaw. (n.d.). Retrieved January 10, 2021, from https://www.rheumatology.org/I-Am-A/Patient-Caregiver/Diseases-Conditions/Osteonecrosis-of-the-Jaw-ONJ
  • Sozen, T., Ozisik, L., & Basaran, N. C. (2017). An overview and management of osteoporosis. European Journal of Rheumatology, 4(1), 46-56. doi:10.5152/eurjrheum.2016.048